An update from Indivior ( (GB:INDV) ) is now available.
Indivior PLC announced that Dr. David Wheadon, the Chair of the company, has acquired 10,000 ordinary shares at an average price of $8.4281 per share. This transaction highlights Dr. Wheadon’s confidence in the company’s future prospects and could have positive implications for stakeholder sentiment and the company’s market positioning.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, specializing in the development and commercialization of medications for the treatment of addiction and serious mental illnesses. The company focuses on providing innovative treatment solutions to improve the lives of patients worldwide.
YTD Price Performance: -36.43%
Average Trading Volume: 302,050
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £810.1M
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.